Team
Partner
Mark H. Lewallyn
New York
Mark Lewallyn is a Partner based in New York having joined Centerview in 2016 as a founding member of its market leading healthcare services and technology practice. His experience includes sell-side and buy-side M&A, spin-offs, divestitures, special committee assignments, shareholder activism defense, and restructurings, and general strategic advisory. Over the course of his career, he has advised on more than 50 transactions with aggregate value of approximately $350 billion.
Representative transaction experience includes:
Pharmacy and Supply Chain
Payors, Providers, and Value Based Care
Pharma Services
Healthcare Technology
Before joining Centerview, Mr. Lewallyn worked in the Global Healthcare Group at Credit Suisse. Prior to pursuing a career in finance, he worked as an M&A and Capital Markets attorney in the New York office of Gibson, Dunn, & Crutcher.
He received his J.D. from the University of Virginia School of Law and his B.S. from Samford University where he was a four-year letterman on the Division 1 baseball team. He lives in Connecticut with his wife and two young children.
Representative transaction experience includes:
Pharmacy and Supply Chain
- Express Scripts on its $67 billion sale to Cigna
- Blackstone, Carlyle, and H&F on their $34 billion acquisition of Medline
- Walgreens in its $24.1 billion sale to Sycamore Partners
- PANTHERx in its sale to Warburg Pincus
- Option Care Health in its $5.8 billion sale to CD&R and McKesson
- Cardinal Health on its $3.9 billion acquisition of GI Alliance
- Comprehensive Pharmacy Solutions on its $2.8 billion sale to Optum
- Shields Health Solutions on its $2.5 billion sale to Walgreens
- Genoa Healthcare on its $2.5 billion sale to Optum
- Solaris Health in its $2.4 billion sale to Cardinal Health
- OneOncology on its $2.1 billion sale to Cencora and TPG
- BioPlus on its $1.6 billion sale to Elevance Health
- CarepathRx Health System Solutions on its $1 billion sale to Cigna
- Shields Health Solutions on its sale to Welsh Carson and Walgreens
- Pharmscript on its sale to Optum
- OneOncology on its acquisition of United Urology
Payors, Providers, and Value Based Care
- Oak Street Health on its $11 billion sale to CVS Health
- Surgery Partners in its $5.7 billion sale to Bon Secours Mercy Health
- Cigna on its $3.7 billion sale of its Medicare Businesses and CareAllies to HCSC
- Landmark Health on its $3.3 billion sale to Optum
- CareBridge on its sale to Elevance Health
- HealthSun on its $2.1 billion sale to Elevance Health
- Anthem on its $1.5 billion acquisition of America’s 1st Choice
- Humana on its $725mm acquisition of Enclara Pharmacy
- Action Behavior Centers in its equity recapitalization
- Physicians Endoscopy in its sale to UnitedHealth
- InnovAge on its sale to Apax Partners
- Molina Healthcare on its terminated acquisition of NextLevel Health
- EyeCare Partners on its refinancing transactions
- Rural Medical Group on its acquisition of Steward Medical Group
- TA Associates on its acquisition of IMA Medical Group
Pharma Services
- ICON on its $12 billion acquisition of PRA Health
- PPD on its $9.1 billion recap with Hellman & Friedman and Carlyle
- Syneos on its $7.1 billion sale to Elliott, Patient Square and Veritas
- INC Research on its $7 billion merger of equals with inVentiv Health
- inVentiv Health on its $3.7 billion sale to Advent
- Linden Capital Partners in its $2.5 billion acquisition of Klick Health
- Precision Medicine Group in its $2.3 billion sale to Mckesson
- PharmaCord on its $1.5 billion sale to Permira
- Cencora on its divestiture of its Lash Patient Services business
- Kohlberg on its acquisition of Worldwide Clinical Trials
- UBC, a subsidiary of Express Scripts, on its sale to Avista Capital
Healthcare Technology
- MultiPlan on its $11 billion combination with Churchill Capital
- Fullscript in its sale to Altas Partners and L Catterton
- MedRisk on its sale to CVC Capital
- TransUnion RCM, a subsidiary of TransUnion, on its $1.7 billion sale to nThrive
- Fresenius Medical in Humacyte’s $1.1 billion merger with Alpha Health
- Merger of Symphony Real World Data (a subsidiary of ICON plc) with HealthVerity
- ExactCare on its $570mm acquisition of Tabula Rasa
- Francisco Partners in investments in multiple new HCIT platforms
- Kohlberg on its acquisition of Trinity Life Sciences
- Wellframe on its sale to Healthedge Software
- EQT on its acquisition of Certara
Before joining Centerview, Mr. Lewallyn worked in the Global Healthcare Group at Credit Suisse. Prior to pursuing a career in finance, he worked as an M&A and Capital Markets attorney in the New York office of Gibson, Dunn, & Crutcher.
He received his J.D. from the University of Virginia School of Law and his B.S. from Samford University where he was a four-year letterman on the Division 1 baseball team. He lives in Connecticut with his wife and two young children.

